MYC and ovarian endometrioid carcinoma: We also studied the consequences of shRNA-mediated inhibition of CTNNB1 on MYC gene expression in the TOV112D human ovarian endometrioid carcinoma cell line that harbors a CTNNB1 oncogenic mutation leading to β-catenin/TCF dysregulation [33].